Market Snapshot

S&P Futures
4,400.75
Dow Futures
34,951.00
NASDAQ Futures
15,109.75

126.61$9.01 7.66%
Market open    13:57:10 pm   
From: To:

Stock Snapshot

117.60
Prev. Close
118.10
Open
5.21B
Market Cap
3.76M
Number of Shares
112.72
Day Low
130.33
Day High
126.61
-
P/E Ratio
37.44M
Free Float in %
-0.28
EPS 2021
7.45
Book Value per Share
6.85
Cash Flow per Share
Cassava Sciences, Inc. (SAVA)
Cassava Sciences, Inc. (SAVA) stock rallied over 7.66% intraday to trade at $126.61 per share on NASDAQ. The stock opened with a gain of 0.43% at $118.10 and touched an intraday high of $130.33, rising 10.82% against the last close of $117.60. The stock went to a low of $112.72 during the session.

Historical Prices

DateOpenCloseAdj. CloseDaily HighDaily LowVolume
2021-06-30$82.48$85.44$85.44$87.65$80.792,089,944
2021-06-29$85.09$82.97$82.97$85.74$80.761,725,600
2021-06-28$80.34$85.48$85.48$87.10$79.352,816,300
2021-06-25$81.36$78.41$78.41$84.25$78.383,368,300
2021-06-24$79.23$81.46$81.46$87.28$79.113,060,600
2021-06-23$80.70$77.56$77.56$81.45$74.722,488,100
2021-06-22$88.43$77.63$77.63$89.15$72.486,482,300
2021-06-21$80.52$89.72$89.72$92.50$79.014,450,300
2021-06-18$78.00$79.65$79.65$81.48$77.751,745,500
2021-06-17$78.81$78.60$78.60$82.80$77.872,056,300
2021-06-16$72.00$80.27$80.27$80.99$71.162,885,600
Cassava Sciences, Inc.
7801 North Capital of Texas Highway
Suite 260
Austin, TX 78731
United States

http://www.cassavasciences.com
512 501 2444
Employees
11
Sector
Healthcare
Sales or Revenue
Industry
Biotechnology
5Y Sales Change
-
Fiscal Year Ends
2020-12-30
Mr. Remi Barbier
Founder, Chairman, Pres & CEO
Mr. Eric J. Schoen
Chief Financial Officer
Dr. Nadav Friedmann
Chief Medical & Operating Officer and Director
Cassava Sciences, Inc.
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for nervous system disorders. Its lead therapeutic product candidate is PTI-125, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was founded in 1998 and is based in Austin, Texas.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam